Skip to main content
Premium Trial:

Request an Annual Quote

ChromaCode Raises $28M in Series C Financing

NEW YORK – Molecular diagnostics firm ChromaCode said on Tuesday that it has raised $28 million in Series C financing.

The company plans to use the new funds to accelerate development of ChromaCode's high-definition PCR products for digital PCR and real-time PCR platforms.

Funds will also be applied toward expanding partnerships with leading companies in molecular infectious disease, reproductive health, and precision medicine for oncology, the firm said, as well as to support commercialization of ChromaCode's new multi-drug resistance and tick-borne pathogens multiplex panels. 

The financing round was led by Northpond Ventures, with participation from new investors Windham Ventures, Moore Venture Partners, and the California Institute of Technology, as well as existing investors New Enterprise Associates (NEA), Domain Associates, and Okapi Ventures.

In a statement, NEA's Carol Gallagher said that technologies that advance the state of the art typically enter the market at a higher price point, but ChromaCode's approach "provides an unprecedented opportunity to respond to emerging demands for more comprehensive clinical diagnostic tools in an extraordinarily cost-efficient manner."

The new funding adds to $12 million Carlsbad, California-based ChromaCode raised in a Series B round in 2017 and $2.5 million it raised in a Series A round in 2015.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.